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Influenza
Jack Edwards,

'55

INTRODUCTION
The word "flu" today encompasses such a large variety of vague ailments
and symptom-complexes that it would be impossible to discuss them aJI in this
paper. Respiratory flu often refers to the common cold, and when a person says
he has had stomach flu , it usually means he has spent a miserable night running
to the toilet. In this paper, I shall attempt to describe influenza in its pure form.
Before 1890, influenza was practicaJiy unknown, and except for a minor outbreak in 1855, was not a significant cause of death. In fact, it was becoming an
almost extinct disease in Britain. .According to Burnet and Clark, influenza remained endemic somewhere in Central .Asia until the spring of 1889, when its
virulence became exalted in Bukhara. Other parts of Russia were affected in the
fall , and by December the epidemic had spread to Western Europe. The 1889-90
pandemic affected a large part of the world but was not associated with particularly high mortality for young adults. The first wave in January 1890 was
succeeded by others in May 1891 and January 1892, causing progressively high
mortality. Influenza has never since fallen to the pre 1889 low level and has
become an important cause of mortality and morbidity in most temperate climates.
In 1918-19, influenza accounted for the most lethal pandemic known in history. .According to Frost, there had been a steady increase in the mortality from
influenza and pneumonia in New York betwee.n 1914 and 1918. It is questionable
whether this progressive rise can be ascribed to the activity of influenza .A, or of
any other single virus. In fact it is not known what led to the catastrophic events
of 1918-19. In the early months of 1918 the influenza had no unusual properties,
but in June in Britain, there was some indication that it was beginning to kill
young adults. The really virulent form of the disease appeared at about the same
time in the U.S.A. around Boston, and in Brest France - ports of embarkation
and debarkation of .American troops corning to Europe. The rapid spread of the
lethal kind of influenza all over the world is a familiar story. It is estimated
that at least 15 million people died as a result.
Mter the pandemic years, influenza gradually returned to its habits of killing
the old and weak, rather than the young and vigorous. This reversion took at
least three years in the U.S.A. and perhaps a decade in Britain. We may suppose
that the 1918-19 influenza lacked some property enabling it to persist between
epidemics, so that a less spectacu lar derivative gradually replaced it.
Since the great pandemic the mortality from influe.nza has been falling and
the peaks have been tending to be smaJier and more widely spaced. However,
influenza is still an important cause of morbidity and lost working time as witnessed in London this winter.

DEFINITION AND ETIOLOGY
Influenza is an acute, suddenly onsetting, infectious disease of viral etiology,
usually occurring in epidemic form and
characterized by general symptoms of
fever, chills, headache, myalgia, and by
mild upper respiratory symptoms.
In 1892 Pfeiffer described a small gram
negative bacillus, which grew with difficulty upon blood media, as the causative agent of influenza. It is known as
Pfeiffer's bacillus or Hemophilus influ-

enza and bas since been proved to be only
a common secondary invader of influenza.
In 1933 the true etiology was established in England by Smith, Andrews, and
Laidlaw, with the isolation of a vi rus from
gargling of patients, during a typical
epidemic of influenza. It was designated
influenza A virus.
In 1940 a second etiological type of the
virus was isolated independently by Francis and Magill, known as influenza B
VICUS.
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A third type of virus, unrelated to
either influenza virus A or B, was discovered in 1947 by Taylor, and the name
influenza virus C was proposed.
In electron-micrographs of infected
allantoic fluid, purified by centrifugation
or by absorption on red-cell ghosts, the
virus is seen as round or slightly ovoid
particles measuring 80- 120 millicrons in
diameter. The average size of influenza
B virus is slightly larger than that of A.
In addition, elongated forms have been
observed, either as long filaments 1 micron or more in length or as shorter rods,
and are thought to represent a laboratory
form of influenza virus. Their exact relationship to the spherical virus is still
incompletely understood.
The virus is readily destroyed by heating, and by treating with disinfectants.
It can be preserved at very low temperatures. The virus can be recovered from
throat washings early in the illness but
has never been found in the blood stream.
Influenza virus consists of at least two
distinct components, the elementary body
and the soluble substance. The properties
of the two differ considerably.
The soluble substance is made up of
small particles with an average diameter
of about 10 millimicrons. Soluble substance can be demonstrated only by complement-fixation tests, in which it acts as
a powerful antigen. Antibodies against
soluble substance develop only after infection, not after vaccination. The particles are not infective, are not absorbed
on red blood cells, and do not cause
hemagglutination.
The elementary bodies are considerably
larger, their diameter being 8- 120 millimicrons. Studies have shown that virus
infectivity is intimately associated with
these bodies. Furthermore, the element·
ary bodies react with red cells and cause
hemagglutination. Animals immunized
with this component develop virus-neutralizing and other antibodies, and be-

come resistant to influenza infection. The
elementary bodies also fix complement in
the presence of immune serum, but the
antigen is different from that of the
soluble substance.
The strains of human influenza virus
known at the present time can be divided
into three distinct and immunologically
unrelated types which are referred to as
influenza A, B and C. In addition there
are the swine influenza viruses which are
serologically related to influenza A virus.
While A and B viruses have been widely
investigated, not much is known about
the antigenic structure of influenza C
virus.
The soluble substance contains only a
single antigen which is type-specific, that
is, all strains of influenza. A virus contain the same soluble antigen, which is
quite distinct from that present m mfluenza B virus strains.
The elementary bodies contain several
distinct antigenic components, and individual strains belonging to the serological type virus may differ considerably
from one another as regards antigenic
constitution. Thus, although all influenza A strains are immunologically related, marked differences in the antigenic
pattern of individual strains can be easily
differentiated in cross-tests with different
virus strains and their antisera. Similar
variations have been recognized also
among individual strains of influenza B
virus, whereas only one serological type
of influenza C is known.
Comparisons of antigenic pattern of influenza virus strains can be carried out
by a number of methods, such as crossneutralization tests in mice, and hemagglutination-inhibition and complementfixation tests using elementary-body suspensions as antigen. In recent years, the
hemagglutination-inhibition test has been
preferred by most workers because it is
technically the simplest and is the least
expensive me~hod.
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Attempts have been made to segregate
the virus strains of each serological type
(A, B and C) into subtypes. All strains
of influenza A virus so far examined can
thus be divided into three main groups
according to their relationship to the
following three prototype viruses: WS
(1933) , PR 8 (1934) and FM 1 (1947) .
Similarly the B strains can be subdivided
into two groups with the general characteristics of Lee (1940) and Bon (1943)
viruses.
In 1946-47 there appeared to be a
major shift in antigenic constitution when
the FM 1 (1947) type virus was discovered. Thus, this virus and the FW-150 type discovered in 1950 were designated the A - prime group.
Studies of the antigenic vanattons
among influenza viruses are of importance not only for the better understanding of the epidemiology of the disease,
but also for problems associated with the
procuring of an effective vaccine against
it. It has been clearly established that a
vaccine made from the strains which differed considerably from the epidemic
strain in question, did not protect against
the disease. However, minor variations
may not influence the effectiveness of the
vaccine too much.
The mechanism responsible for the
changes in the antigenic pattern of influenza virus cannot be satisfactorily explained at present. One theory is that
influenza viruses are constantly mutating
and that entirely new antigenic types appear occasionally. Another theory states
that influenza viruses contain a large but
finite number of antigenic components
which may be present in different combinations and proportions. Changes in
antigenic pattern may be the result of
selection or rearrangement induced by
environmental factors such as passage 1n
partially immune human hosts.
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CLINICAL ASPECTS
The exact mode of transference of influenza from man to man is unknown,
but is presumed to be by the inhalation
of infected droplets, discharged into the
air during the process of talking, coughing and sneezing.
The incubation period lasts from 24-72
hours and terminates in a sudden onset
of illness with headache and/or shivering. Sometimes a vague onset occurs
after premonitory symptoms of cough,
so re throat or a cold. More often the
patients can tell the hour of onset by a
sudden backache or headache or sneezing.
Rarely, ,a fainting spell may be the initial symptom. Following the initial symptoms, the patient usually recognizes a
rapid worsening of his condition with
headache, anorexia, prostration and muscular aching. The symptoms all tend to
be more severe in the older age group.
The temperature rises sharply to a peak
and thereafter may decrease slowly or
become totally irregular. The duration
of fever averages 72 hours but may
last only 48 hours. Once the temperature has reached its peak, constitutional symptoms diminish and symptoms arising from the respiratory tract
become more prominent. The nose is
either running or blocked ; cough is invariable but sputum is raised in less than
one-third of uncomplicated cases. Sore
throat and hoarseness occur in about onehalf of cases. Chest pain, usually substernal in location, is felt in about onequarter of the patients. Throughout the
fever, there may be continuing headache
or muscular pains, anorexia and nausea
may be present, and sleep is disturbed.
According to Stuart-Harris, influenza
virus infection can be accompanied by
nausea and vomiting, particularly at the
onset of the disease, but persistent vomiting and diarrhea is exceptional. He
states that epidemics of nausea and vomit-
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ing must be due to an entirely different
agent or group of agents.
Confusion between influenza and the
onset of encephalitis lethargica and poliomyelitis probably accounts for the occasional " nervous" forms of influenza, although a mutant strain of influenza virus
with neurotropic properties has been produced in the laboratory.
Characteristically the patient gives the
appearance of extreme weariness and has
no desire to interest himself in any activity other than sleep. There is flushing of
the face at the height of the fever and
slight cyanosis of the lips may be evident.
Apart from the general appearance of
the patient and physical signs in the respiratory system, the signs are few. The
eyes often show slight lacrymation and
the conjunctivae are mildly suffused. The
nose is not so much afflicted by discharge
as by being blocked and dry. The pharynx
appears normal in some cases. In others
it is injected, with prominent vessels an·d
swollen adenoid tissue, and in a few patients a dry granular appearance of the
pharyngeal wall may be seen. Cervical
adenitis is not prominent, though tonsillar glands may be slightly swollen. The
voice is often affected, but actual aphonia
is rare.
The chest often is clear of physical
signs throughout the illness, but in about
one-third of uncomplicated cases there
are a few loose rales or scattered rhonchi
which soon clear up. In such patients
there may be a productive cough with
greenish mucopus. In general, however,
the cough is dry. The pulse varies greatly,
tachycardia being more common during
the acute phase, and bradycardia in convalescence.
The tongue is frequently coated but
the abdomen is normal. Albuminuria is
not more than that associated with any
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fever. Slight leukopenia
mon than leukocytosis.

IS

more com-

DIAGNOSIS
The diagnosis of a case of influenza
can most often be made by the appearance of the typical clinical picture occurring during an epidemic. A diagnosis of
influenza between epidemics should be
made with caution. Ordinary lab tests are
of little use in establishing a diagnosis.
The finding of leukocytosis usually indicates the presence of a bacterial complication. The sed rate is slightly elevated
during convalescence.
The positive diagnosis of influenza
virus infection depends upon the investigation of individual patients by attempts
to recover influenza virus from their
secretions, or by tests for antibodies in
their sera.
Ferret innoculation has been used to
demonstrate the influenza virus, but it is
now practised chiefly as a method for
the production of immune convalescent
serum.
The most common method used to recover the virus is as follows: suspected
patients gargle with a sterile broth-saline
mixture, preferably within the first two
days of illness, and deposit the fluid into
a sterile container. Antibiotics are added
to the specimen to kill bacteria and 0.2
ml. of treated garglings is injected
amniotically into fertile hens' eggs previously incubated for 13 days. These eggs
are then incubated again for four days,
at which time the amniotic fluid is collected and mixed with a 1% suspension
of each fowl and guinea-pig red blood
cells. Red-cell agglutination at dilutions
of 1:10 to 1:160 indicates influenza virus
infection. Proof that hemagglutination is
due to influenza virus is obtained by titration of positive fluids against immune
sera which inhibit specifically influenza
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virus A or virus B hemagglutination. Also,
antigens can be prepared from the amniotic membrane and tested against specific
sera by the complement-fixation test.
In the examination of human sera for
antibodies, a sample is obtained early in
the disease and the titre of antibody is
compared with that in a sample of serum
obtained during the convalescent stage.
The sera can be tested by one of three
different methods; either by examination
for neutralizing antibodies against living
virus, which necessitates the use of mice
or chick embryos, or by in vitro methods,
namely the hemagglutination or Hirst test
and the complement-fixation test. Diagnosis is based upon the demonstration of
a four-fold or greater concentration of
antibody in the convalescent serum compared with that present in the first serum.
While these complicated laboratory
tests are used in experimental and epidemiological studies, they are impractical
in the diagnosis of individual cases of
influenza.
Influenza must be differentiated from
psittacosis, Q fever, febrile catarrh, primary atypical pneumonia and pyrexia of
unknown origin. Other conditions which
may onset with influenza-like symptoms
are pyelitis, enteric fever, tuberculosis,
brucellosis, subacute bacterial endocarditis, infectious hepatitis, Weil's disease,
glandular fever, the leukemias, Hodgkin's
disease and the reticuloses in the earlier
stages.

COMPLICATIONS
The most important complications of influenza are paranasal sinusitis, otitis media,
bronchitis, bronchiolitis and pneumonia.
A certain degree of paranasal sinusitis
is probably always present but becomes
serious when widespread bacterial infection occurs.
MAY,
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Otitis media and subsequent mastoiditis
may occur from extension of the process
up the Eustachian tubes.
Influenza! bronchitis is seen at all ages
but is a serious condition only in the
elderly or those already afflicted by some
chronic cardiac or respiratory disease.
Mucopurulent bronchitis is suspected
when the initial dry cough of influenza
becomes productive and is accompanied
by signs in the chest such as generalized
rhonchi or sneezing, and mild dyspnea.
It varies in severity and usually clears up
promptly in patients with previously
healthy lungs, once the temperature is
normal.
Bronchiolitis is suspected if the temperature remains elevated on the third
day or subsequently if the patient coughs
frequently and has mucopurulent sputum,
and if examination of the chest reveals
patches of fine rales at one or both lung
bases. Such patients become mildly dyspneic but do not complain of pleural
pain. X-rays of the chest may either reveal no abnormality or else show increased
bronchial markings. Recovery, even without antibiotics, is usual. If, however, the
patient has pre-existing disease such as
bronchiectasis, emphysema, or congestive
heart disease, bronchiolitis may cause
death.
Influenza! bronchitis and bronchiolitis
are related to influenza virus infection,
but are also accompanied by invasion with
pathogenic nasopharyngeal bacteria. A
preponderance of Hemophilus influenzae
is found in the most seriously affected
patients.
Influenza! pneumonia with accompanying consolidation may develop during the
course of the febrile phase of influenza
or may follow after the patient bas made
an apparent recovery from the primary
infection. A pneumonic process is suspected when the convalescing pa·t ient
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cough, dyspnea, and pleural pain. Sputum,
which may be mucopurulent, purulent,
or frankly bloodstained, is usually evident
at this stage. Physical signs in the chest
are those of frank consolidation with dullness, often suggestive of a small effusion,
bronchial breathing, and abundant rales.
Rales may also be evident in other areas
where dullness cannot be elicited. X-ray
of the chest usually shows scattered areas
of relatively dense opacity resembling a
bronchopneumonia.
During the great pandemic, fulminant
influenza! pneumonia was often seen. It
is characterized by the rapid development
of extreme dyspnea and prostration in
an apparently simple case of influenza.
Within a matter of hours, the patient is
dangerously ill and presents a shocked appearance, with livid or heliotrope cyanosis, sweating, tachycardia, and a low
blood pressure. The temperature, which
may be high initially, falls steadily and
may be subnormal at the time of admission. Cough and sputum may be absent,
but in some patients there is a frequent,
ineffective cough, raising only a little
frothy or bloodstained sputum. Physical
signs in the chest are: numerous widespread rales and weak breath sounds;
dullness is usually absent. As the illness
progresses, there are bouts of extreme
dyspnea with great restlessness. The
mentality is usually lucid until death,
which often occurs within 48 hours. If
the patient survives, the typical picture
of consolidation appears.
All fatal cases of influenza, except possibly some of those in the aged or enfeebled are attributable to bacteriological
action . Pneumococci predominate in the
sputa of patients who develop pneumonia
some days after the onset of influenza.
Pyogenic staphylococci occur in a Jesser
percentage of cases, but particularly in
cases concurrent in time with the influenza virus infection. Occasionally hemo-
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lytic streptococci or Klebsiella pneumonia
are the invading organisms.
It is debatable to what extent · the influenza virus is responsible for influenza}
pneumonia and how much is due to bacterial invasion. Some authors believe that
the virus infection is limited to the
pharynx, and others think that it is responsible for the epithelial lesions of the
trachea and bronchi. It is unlikely, except in cases of severe and fulminant
pneumonia, that the virus plays a role in
continuing pulmonary infection, and thus
treatment directed towards the bacterial
component is usually adequate. However,
the virulent virus of 1918 probably had
definite pneumotropic properties.

PATHOLOGY
No one has convincingly demonstrated
that influenza virus unaccompanied by
bacterial superinfection will produce a
necrotic epithelial reaction in the trachea
or bronchioles in man, so that pathological reports are confusing. The characteristic feature most often described is
a necrotising process of the surface ciliated columnar epithelium of the trachea
and bronchioles.
In Staphylococcal influenza! infection,
the entire bronchial mucosa is converted
into a mass of fibrin enmeshing necrotic
cells and leucocytes, and resembling granulation tissue. The lung itself shows
edema fluid and intense congestion, with
alveoli choked with red cells, or else an
organizing exudate of polymorphonuclear cells. Actual focal abscesses may be
found. Exudate and swelling bronchiolar
epithelium often leads to obstruction and
atelectasis of the alveoli.
In mild cases of influenza, a diffuse inflammation of the respiratory tract from
the nasopharynx to the bronchioles is
usually found .
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EPIDEMIOLOGY
Epidemics of influenza occur in winter
or early spring and are characterized by
their explosive spread. They usually reach
a peak in 2 to 3 weeks and subside gradually over a period of 4 to 8 weeks.
Influenza A epidemics in America occur
at intervals of 2 to 3 years and influenza
B at intervals of 4 to 6 years. Therefore,
it would seem that immunity is of relatively short duration. Most of the population become immune during an epidemic
either by illness or subclinical infection.
This immunity reaches a maximum in 2
to 3 weeks and is responsible for the gradual subsidence of the epidemic.
Several theories have been evolved as
to the origin and spread of epidemics.
The first, or latent virus theory, is that
the virus "goes underground" at the end
of a period of epidemic prevalence. It
exists in some form of latent infection,
perhaps in some remote corner of the
respiratory tract, or in an animal reservoir, in which state it cannot be detected
by normal methods of investigation. This
theory postulates that at a certain time,
when conditions are ripe, the latent infection becomes manifest and spreads
through the susceptible population.

by the virus, but it is dear that global
study of influenza epidemiology is the
only way to solve the problem of the
origin of the epidemic.

VACONATION
The initial studies on vaccination of
human subjects with influenza virus were
undertaken to determine whether the administration to man of active virus by the
subcutaneous or intracutaneous routes
would incite infection, and in order to
gain evidence of the degree of antibody
response which could be elicited. Utilizing the PR 8 strain of type A virus, it
was found that virus propagated in chick
embryos given by either route, did result
in the production of neutralizing antibodies to titres comparable with those of
convalescent patients. The peak was
reached in the second week, and a relatively high level persisted during a period
of 6 months.

The second theory concerning the persistence and spread of human influenza
is that the virus exists by a continual
case-to-case transmission . This pre-supposes that there is always an outbreak of
influenza somewhere in the world, and
that as influenza dies out in one country,
it develops anew in another area. The
alteration between the winter seasons in
the Northern and Southern hemispheres
furnishes a possible mechanism for the
continuous survival of virus, as also do
studies of the spread of epidemics from
one country to another.

In 1936 Stokes and Shaw reported an
incidence of febrile illness in 2.7 % of a
g roup of children innoculated ~ith a
mouselung suspension of human virus A,
and 12.5% in a control group, during an
influenza epidemic. Further controlled
studies were carried out over the next
few years, but there was little consistent
evidence that subcutaneous vaccination
afforded effective protection against influenza in times of epidemics. It was
thought that if influenza was not prevented in the vaccinated individuals it was
because (a) the vaccine was not of sufficient potency to excite antibodies to uniformly adequate levels, (b) the strains in
the vaccine were not sufficiently similar
to those causing the epidemic, or (c) the
level of antibodies in the blood, resulting
from vaccination, was not sufficiently
high to control influenza.

No one can say which of these two
modes of survival is the method adopted

In 1940, Hirst, Rickard, Whitman and
Horsfall carried out a study comparing
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They found with active influenza virus,
that the antibody titres attained increased
as the amount of virus in the innoculum
increased. A tenfold concentration of A
virus and a fourfold concentration of B
virus was suggested as optimal. In 1942,
two groups of investigators demonstrated
that virus could be concentrated from
allantoic fluid by freezing and then thawing at a low temperature. This concentrated vaccine, when inactivated, induced
better antibody responses than had been
obtained with unconcentrated vaccine, and
as good as those with active centrifugal
material. From 1942-45 extensive studies
using the new concentrated inactivated
vaccine were carried out at Cornell University, University of Michigan, Yale, and
Alabama in the U.S.A., Glasgow, Scotland,
and Woolwich, England. All the results
were definitely in favour of the vaccine.
After a lapse of three years from the
influenza A epidemic of 1943, an outbreak of the disease was anticipated in
the winter of 1946-47. At the end of
October, 1946, a vaccination study was
again instituted at t he University of
Michigan and 10,328 persons received
vaccine containing the same strains as in
previous years. 7,615 were unvaccinated.
When influenza occurred in March 1947,
no evidence of protective effect was demonstrated in the immunized group. Here,
the incidence was 7.19% as compared
with 8.09% in the control group. It was
apparent that a new virus strain had appeared and that the antibodies produced
by the old strain were not effective against
it. That the new strain was of type A,
was shown by the fact that the majority
of convalescent patients exhibited an antibody rise to PR 8 or to other A strains
as proved by hemagglutination-inhibition and other tests. The new antigenic
variant was designated A prime, FM 1
(1947) and the Commission on Influenza recommended that it be incorporated
into subsequent vaccines.
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Studies over the next three winters
proved the efficacy of the new FM 1 vaccine. Epidemics in the years following
1947 have shown a prevalence of A-prime
influenza infection, and recent studies
using only A-prime strains indicate a
high degree of protection, although the
epidemic strain may differ serologically
from that of the vacc·ine.
The accumulated evidence with epidemics caused by the A-prime strains has
shown that protection can be obtained by
the use of vaccine strains which are not
identical with those prevalent. This is
important with regard to both crossimmunity and antigenic composition.
A number of early studies suggested
the possibility of using lipids to enhance
the antigenic activity of influenza virus.
Recently Salk and his associates have conducted extensive investigations of the use
of virus first emulsified in mannide monooleate, and then suspended in a light
mineral oil. The titres obtained with
these adjuvant vaccines greatly exceed
those obtained with similar amounts of
virus in aqueous vaccine, and also the cost
of its production is considerably less than
that of aqueous vaccine.
Vaccination against influenza has been
shown to be uniformly effective under a
variety of conditions when vaccines of
proper constitution and potency are employed. Although epidemological and
serological data have indicated the probability that strain differences are important in the recurrences of influenza, the
degree of variation so far observed is a
limited one, representing more of a rearrangement of viral components than
complete loss or gain of basic constituents. Francis states that current analyses
strongly support the concept that the
antigenic constitution of influenza virus
of a particular type can be mapped. It
is the expectation, then, that vaccine can
be so composed as to contain the differ-
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ent antigenic components required, and
will induce the broad resistance which
otherwise is acquired only by repeated
exposures to the disease. There remains
the problem of virulence, but most of
the data indicate that even highly virulent strains can be counteracted by adequate vaccination or by infection with
mild strains. Moreover, relatively new
antigenic strains are not necessarily highly virulent as evidenced by the mild character of A-prime strains in 1946-47.
In conclusion, the outlook for increasingly broad prophylactic immunization
against the range of influenza viruses is
extremely promising.

TREATMENf
There is no specific treatment for influenza virus infect,ion. The only answer
at the present time appears to be prophylactic immunization, but since recent
influenza epidemics have been so mild,
and since the immunity conferred by available vaccines only lasts about six months,
this would seem -impractical.
Influenza patients should be isolated
during the febrile stage of the illness.
This is not so much to prevent the spread
of the epidemic as to protect the patient
from bacterial contamination while his
respiratory tract is in such a susceptible
state. Bed rest is advocated in a warm,
humid room. Aspirin every four hours
until symptoms subside is probably the
best medication. Other symtomatic measures are: an icecap for headache, massage and alcohol rubs for myalgia, a soothing cough mixture or steam inhalations
for the dry cough, and a barbiturate for
insomnia.
Patients should have a high fluid intake to replace fluid lost by sweating, and
a light wholesome diet during the acute
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phase of the illness. Good nursing care,
and reassurance of the short duration of
the condition are very important.
The patient should be kept in bed until at least one day after the pyrexia has
disappeared, and a more prolonged bedrest is needed if there is continued cough
and expectoration, or in elderly subjects.
In any case, cough should have disappeared before normal activities are resumed, and additional care should be
exercised in any subjects with previous
chronic chest disease.
The question which is often raised, is
whether routine use of chemotherapeutic
agents would diminish the risk of secondary bacterial infections of the bronchi or
lungs after influenza. There is no certain knowledge that chemo-prophylaxis
would be effective, and the risk of such
possible complications is small. Chemoprophylaxis should therefore be reserved
for patients in the older age-groups or
with previous chest disease, such as
chronic bronchi,tis or bronchiectasis, particularly if persistent signs in the chest
are still present by the third day of influenza. Influenza in subjects with chronic
heart disease should also be considered
as an indication for chemo-prophylaxis.
With the onset of severe bronchiolitis
or pneumonia, adequate dosage of appropriate antibiotics should be given at once.

CONCLUSION
In this paper, the various aspects of
influenza and its complications have been
discussed in an attempt to clarify the confusing Flu symptom-complex. Although
mortality due to influenza is declining, it
is still a serious cause of morbidity. The
ultimate control of the disease depends
upon the discovery of a vaccine which
will confer long-lasting immunity against
all strains of the influenza virus.

Hepatic Coma
Velta

J. Cemavskis, '55

INTRODUCTION
Hepatic coma is a form of disturbed or impaired consciousness which may
be observed in the course of liver disease.
This condition, however, is not the only disorder which may be associated
with the downhill course of hepatic disease. The generally debilitated patients
are 'S usceptible to infection. Cirrhosis leads to hypoglycemic attacks. WernickeKorsakoff syndrome and delirium tremens can be associated with liver disease
and give rise to neurological symptoms if chronic alcoholism happens to be the
cause of cirrhosis.
Even death following liver disease is not always preceded by hepatic coma.
According to Lichtman, terminal liver disease may take three courses:
(I) the patient succumbs due to infection of liver or biliary passages with
its accompanying toxem ia;
( 2) hepatic involvement leads to chronic portal stasis, recurring ascites, failing nutrition, and toxemia which are the causes of death;
(3) the patient may die in hepatic coma.
This paper will discuss hepatic coma- " the tragedy of the last act of liver
disease" as Eppinger called it. An attempt will be made to outline the course of
events associated with this condition, and to give the changing thoughts on pathogenesis and management.

IDSTORY
Since early times central nervous system changes during the course of liver
disease have been observed. Galen had
referred to it in his writing: ". . . bills
ad caput recurrens delirii causa" - jaundice is the cause of recurring delirium.
Franciscus Ruboeus (1"660) is credited
with the earliest description of acute yellow atrophy. Morgagni (1761) collected
classic descriptions of the fatal delirium
associated with liver disease from the
writings of Baillou, Guarinonius, and Valsalva which showed jaundice followed by
coma and death. Griffin (1834), Bright
(1836), and Budd (1845) also described
acute fatal jaundice with mental and
neurological changes. Bright's description
included such typical signs and symptoms
of hepatic coma as dilatation of the
pupil, irregular jerky movements of the
limbs, flexion of knees against abdominal
wall, difficulty of articulation, and attacks
of screaming followed by coma and death.
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Frerichs, who recognized the gravity of
delirium as a symptom of jaundice and
analyzed the symptom-complex in 31 cases
of acute liver failure, is said ·t o be the
father of modern study of liver disease.
Since then many men have contributed
to the description and understanding of
the condition, but a complete historical
account is outside the scope of this paper.

ETIOLOGY AND INCIDENCE
Any type of hepatic disease may lead
to hepatic coma. All these underlying conditions, however, may be divided into two
large groups:

(1) acute yellow atrophy
(2) chronic liver disease
By acute yellow atrophy is meant any
severe form of hepatitis due to many unrelated causes characterized by extreme,
progressive disturbance of the liver function. These cases usually run a short
course, terminating in coma.
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When the coma is superimposed on
chronic liver disease such as portal or
biliary cirrhosis, carcinoma of liver, or the
Budd-Chiari syndrome, the course of the
disease is usually not so fulminant, and
often some precipitating factors are held
responsible for the patient's lapse into
coma. In these cases infections, hemorrhages, repeated paracenteces, high protein diet, ammonia-containing compounds,
morphine, demerol, barbiturates, paraldehyde, anoxia, shock from any cause, and
surgical procedures are known as comaprecipitating factors. Of course, all these
factors may also add to the gravity of
coma when it has developed on the basis
of acute yellow atrophy.
In surveying the literature no reliable
figures on the incidence of hepatic coma
were found because few large series have
been studied. There were 11 cases of
hepatic coma in one year at the Philadelphia General Hospital. The incidence
of coma in cases of cirrhosis has been
given as from 16 to 42% in different
series of cases studied. Children may be
affected, as well as adults, and in children
coma usually bears a graver prognosis
than in adults.

CLINICAL PICI'URE
Adams and Foley {1949) described the
clinical syndrome of impending coma.
The signs and symptoms are largely neurological and may be described under three
headings: changes in mental status; characteristic tremor; electroencephalographic
changes.
All mental processes are slowed. The
patient is drowsy, apathetic, and lethargic.
With increased clouding of consciousness
the ability to perform coordinated movements skillfully is lost. The patient may
become disorientated, confused, or quite
often restless, agitated, and irritable before the stupor deepens into coma. Despite

all these symptoms the patient may maintain that he feels well.
The characteristic tremor is best seen when
the patient holds his arms forward with
hands and fingers extended. Coarse irregular flexion-extension movements of
the fingers and wrists are seen which
have been described as having "flapping"
quality. Occasionally the tremor involves
even upper and lower extremities, and
facial muscles.
Not all patients with impending
hepatic coma exhibit electroencephalographic
chattges. Some degree of slowing of waves
may be associated with disturbance of consciousness from any cause. But in this
c~ndition, bursts of bilaterally synchronous slow waves about 2 to 3 per sec. alternate with intervals of normal activity. As
the coma deepens the slow waves persist
throughout the tracing, spreading from
frontal areas where they make their first
appearance to other areas. If not pathognomonic typical triphasic waves are said
to be extremely suggestive of hepatic
coma. The frequency of waves is the
same from patient to patient, and in the
same patient at different times. The distribution and severity of EEG changes
are roughly related to the severity of
coma.
The patient may recover from impending coma or progress to coma.
The patient, having passed through the
excitable stage of moaning and groaning,
appears to be asleep, and resembles a patient under deep anesthesia with quiet and
regular breathing, responding to very few
stimuli. He can be aroused at first to a
drowsy and stuporous state.
The neurological signs present a complex picture of involvement of cortex,
pyramidal tract, and basal ganglia. Walshe
observed the following signs in 18 cases
he studied:
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---Hepatic C o m a - - - - - - - - - - - - - - - - - " personality changes, mania and coma,
with dilated pupils, choreiform movements of the arms, tonic grasping, and
sometimes lead-pipe and cogwheel rigidity; absent abdominal reflexes, increased knee jerks, ankle clonus, and
extensor plantar responses. In some
patients there was either spasticity or
lead-pipe rigidity of legs. During the
early phase of coma, patients sometimes adopted a characteristic posture
with the legs tightly drawn up against
the abdominal wall. Cranial nerve palsies were rare, convulsions were not
observed. All changes were more prominent in children than in adults."
Loss of consciousness was the only single
feature common to all the cases of hepatic
coma W alshe studied. Pyramidal signs
were the next most commonly observed
neurological abnormality. Usually in later
stages of deep coma the positive signs
of pyramidal involvement disappear and
the extremities may vary from extreme
rigidity to flaccidity. Convulsions are not
a characteristic feature of hepatic coma.
They may occasionally precede death,
however.
Fetor hepaticus which refers to the
characteristic odour on the breath and in
the urine of the patients is found in nearly all cases. But it is said to be also present in the urine of normal persons. The
causative factor of fetor hepaticus is unknown; many speculations have been made
in the past as to whether this unknown
factor might play a role in initiating
hepatic coma.
Temperature and pulse are usually
slightly elevated. Bleeding is common because the hepatocellular damage interferes
with prothrombin formation. Other signs
and symptoms are those due to the underlying liver disease. The clinical picture
may present itself in a variety of forms.
There are no constant abnormal findings.
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PROGNOSIS
Hepatic coma is a reversible condition,
but once coma has occurred the course
of the disease is unpredictable. Sborov
states that 60% of his patients at Washington, D.C., were awakened from coma,
but only 25 % recovered long enough to
be discharged from the hospital. Prognosis is much poorer when coma complicates acute hepatitis than when it is
superimposed on chronic liver disease.
The hepatic necrosis progresses so rapidly that the "point of no return" is often
reached with the onset of coma.
The longer the coma persists, the
poorer is the prognosis. Sborov gives 45
days as the longest known duration of
coma terminating in death, and 12 days
as the longest coma before recovery.
CLINICAL INVESTIGATION

(1) Cerebrospinal Fluid
Cerebrospinal fluid pressure is not
elevated in hepatic coma. Bilirubin of the
direct reacting variety and xanthochromia
have been found in the cerebrospinal fluid
of jaundiced patients in coma, but there
is no correlation between the degree of
hyperbilirubinemia and the amount of
bilirubin in the spinal fluid. An increase
of cerebrospinal fluid protein has been
reported, the significance of which is not
clear.
(2) Blood

The findings of electrolyte disturbances
are not consistent. Some investigators
find that the electrolyte levels are essentially normal, though on the low side
occasionally. Others find altered electrolyte patterns: hypokalemia and lowered
level of magnesia in the blood. Still others
find low serum sodium and phosphorus
or chloride levels. But this disturbance
of the electrolyte pattern may be the re-
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suit of the underlying liver disease because
in alcoholic cirrhosis the dietary intake
is poor, and in hepatitis there is anorexia
and diarrhea.
Frequently a mild metabolic acidosis is
observed both in impending and deep
coma. Moderate hepatic injury may give
rise to elevation of ketoglutaric acid in
the blood. Pyruvic acid is increased only
in the presence of severe hepatic coma.
Lactic acid is also increased. The increase
of blood pyruvate is not specific for
hepatic coma; it is also increased in starvation, nutritional deficiency (especially
thiamine deficiency) , periods of fever,
physical exercise, and large infusions of
glucose. Blood lactate is also increased
in many unrelated conditions.
Chromatographic studies have shown
that there is a marked increase in the concentration of the amino acids glutamine,
cysteine, and methionine in the blood.
Blood ammonia is frequently elevated.
Schwartz and his colleagues investigated
the ammonia patterns of 20 patients with
advanced cirrhosis of the liver who died
in hepatic coma at the Boston City Hospital. Ammonia was expressed as micrograms of ammonia N per millilitre of
whole blood, which represents free
ammonia as well as nitrogenous substances in the blood capable of releasing
ammonia.

Normal

... .. ... ... ... ... .... .

Mean
Value

Range

2.04

1.0-3.0

Cirrhosis .

2.74

Impending coma ...

4.32

2.0-10.0

Coma

6.0

2.0-15.4

The individual values ranged from
normal to highly elevated. Despite the
higher ammonia levels in impending and
MAY,
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deep coma in his observations neither
tremor nor state of consciousness correlated completely with blood ammonia
values. This has also been confirmed by
other investigators. The highest level was
found in a patient who was subjectively
well and working.
Hemoglobin may be significantly decreased. It usually correlates well with
the degree of hepatocellular fairure or
bleeding. Leukocytosis and an absolute
increase in polymorphonuclear leukocytes
are often observed in hepatic disease.
Blood sugar is usually maintained at
the normal level, though hypoglycemia or
hyperglycemia have been reported occasionally. Hypoglycemia may give rise to
neurological symptoms which have to be
differentiated from those usually occurring in hepatic coma. Azotemia is usually
not a part of the picture. Sometimes blood
urea N is elevated terminally.
(3) Liver Function Tests

In the cases Carfagno studied at the
Philadelphia General Hospital, serum
bilirubin was increased in all. The values varied between 1.85 - 30.0 mgm per
100 cc. Serum proteins varied from 5.0
to 7.6 grams per 100 cc. The cephalin
cholesterol flocculation and thymol turbidity tests were positive.
Prothrombin concentration does not depend only on hepatic factors, but its decrease reflects the degree of liver involvement, and failure of response to parenteral administration of vitamin K is a
poor prognostic sign.
There is no liver test, however, which
will indicate the advent of coma. When
the results of hepatic tests in impending
coma and coma are compared, there is no
difference of a sufficient degree to explain the change in the physical status.

73

---Hepatic C o t n : a - - - - - - - - - - - - - - - - - - PATHOLOGICAL LESIONS
Since the times of Rokitansky it has
been known that there are no characteristic changes in the central nervous system
to accou nt · for the diffuse nervous involvement. Foley reported hyperplasia of
protoplasmic astrocytes in lenticular, dentate and other nuclei, but these changes
are hard to correlate with the clinical
find ings. Watson suggested perivascular
encephalopathy, but the general opinion
seems to be that the changes in the brain
are non specific: edema of the brain, congestion of vessels, perivascular mononuclear infiltration and minute focal hemorrhages throug hout t he brain.
. Hepatic coma is not synonymous with
hepatic necrosis, though necrosis has been
frequently found superimposed on the underlying hepatic lesions which precede
development of coma. Malcolm H . Macdonald reviewed eight cases recently dying
from hepatic coma in Toronto General
Hospital. He found that in addition to
their chronic liver changes, they showed
acute lesions ranging from cloudy swelling to centrolobular necrosis. Vigorous
regeneration of liver tissue has occasionally been noted ; these regenerating liver
lobules may or may not be involved by
necrosis. Other patients with cirrhotic
livers died in hepatic coma, and no
necrosis is found at autopsy.
No specific renal lesion has been found
to account for the oliguria and anuria
that a certain number of patients develop
terminally. The kidneys show either bile
nephrosis, lower nephron nephrosis, or
intercapillary glomerulonephritis.

PATHOGENESIS
About 120 years ago Dr. Griffin
described four cases of jaundice in which
the patients went into coma. He asked
at that time, "On what morbid state would
occu rrence of coma in these particular in-
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stances depend?" This question has not
yet been satisfactorily answered.
According to Walshe, any theory which
attempts to account for the pathogenesis
has to explain the following features of
hepatic coma:

(I) the reversibility of all signs and
symptoms;
(2) the variations in the clinical picture and reflex changes from day
to day, and from case to case;

(3) the absence of significant morphological changes in the brain ;
( 4) the lack of consistency in the
laboratory findings;
(5) the occurrence of a clinically indistinguishable coma in acute hepatic necrosis and chronic liver
disease.
Frerichs (1860) originated the theory
that toxic breakdown products of necrotic
liver tissue damage the brain cells. Other
theories tried to explain the symptoms on
the basis of disturbed carbohydrate metabolism due to hypoglycemia or faulty incorporation of pyruvic acid in the Krebs
citric acid cycle; decreased plasma cholinesterase activity leading to acetylcholine
accumulation ; and toxicity of amino acid
imbalance. If hypoglycemia or acetylcholine were the causative factors they would
lead to convulsions, but convulsions are
rare in hepatic coma. In addition, hypoglycemia itself is rare in this condition,
and correction of it does not produce improvement in the clinical status. Also no
improvement is shown when the low
plasma cholinesterase activity is corrected
by administering plasma cholinesterase
concentrate. It was mentioned previously
that increased pyruvate in the blood is
also observed in other conditions and is
not specific for hepatic coma.
Cholemia has been largely discarded as
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a factor in the production of coma as it
was shown that complete biliary obstruction is fatal, but does not produce coma,
and coma may be superimposed on liver
disease when there is only a slight bile
retention .
Recent work has centered around an
inefficient ammonia binding mechanism.
It was in 1927 that Burchi first noted
raised blood ammonia levels in cirrhosis
of the liver. Van Caulaert and Deviller
(1932), and Field (1939) observed drowsiness, coma, and delirium after the administration of ammonium salts in patients
with cirrhosis. After observing symptoms
indistinguishable from hepatic coma on
administration of nitrogenous substances
such as ammonium chloride, diammonium
citrate, urea, and sometimes dietary protein to some of their cirrhosis patients,
Phillips et al (1952) again directed the
attention to blood ammonia as a causative factor. But as mentioned before,
blood ammonia is not directly related to
the degree of consciousness. Cases have
been reported where the onset of coma
preceded a significant elevation of blood
ammonia by twenty-four hours. On several occasions blood ammonia was found
normal on the day of death.
Walshe (1951) suggested that a high
level of intracellular ammonia might be
a possible cause of hepatic coma. Ammonia
is a n intracellular cation which when
present in excessive amounts may interfere with normal nerve cell function giving rise to drowsiness, coma, and death .
Ammonia is released by deamination processes and by breakdown of nitrogenous
substances by the bacteria in the intestine.
It is taken then to the liver via the portal
circulation where its conversion to urea
takes place. However, when the portal
circulation bypasses the liver and enters
the systemic circulation, the ammonia
level in the blood rises. This takes place
in cirrhosis of liver and in Eck-fistula
man and dogs in which there is an estab-

MAY, 195';

lished anastomosis between the portal
vein and the vena cava. Opinions have
differed as to whether the rise of
ammonia observed in hepatic coma is due
only to diversion of portal blood or
whether liver damage is partly responsible
for it too. Clinical observations and experimental evidence seem to suggest that
bypassing of the liver is the most importan t factor. This is shown by the normal
values of blood ammonia in hepatitis.
Also administration of protein and nitrogen in an Eck-fistula man with a normal
liver induces the syndrome of impending
coma.
It has been shown by Krebs, Quastel
( 1935) and Weil-Malherbe (1936) that
glutamic acid is the only amino acid to
support brain respiration in vitro. WeilMalherbe (1950) showed that its role in
supplying energy to the brain is secondary
to its role in the ammonia binding mechanism. Glutamic acid binds ammonia
forming glutamine. Increased ammonia
production may require excessive amounts
of glutamic acid for its detoxification and
produce hepatic coma by interference with
respiration of cerebral tissues. Methionine, which is a glutamic acid inhibitor,
has been found in cerebrospinal fluid of
patients with hepatic coma. Reversal of
hepatic coma has occurred on glutamic
acid administration.

A notable rise in the glutamine content
of the brain has been observed immediately after hepatectomy in animals. The
content rises to 4 or 5 times normal in
24 hours. The absorption of blood glutamine and its transport to the brain was
prevented by injections of large amounts
of insulin in glucose, but the rise of glutamine in spinal fluid continued. What
roles glutamine and intracellular ammonia
play in initiating the coma is not yet
known, but there seems to be at least
some relationship. One must remember
that changes in peripheral blood ammonia
levels are only a rough indication of the
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---Hepatic C o m : a - - - - - - - - - - - - - - - - - - ammonia metabolism in brain cells, and
it would be useful to find some direct
or indirect measurement of intracellular
ammonia.
Singh suggests that at the present time
the blood ammonia levels in hepatic damage should be regarded in much the same
light as the blood urea level in chronic
kidney damage. Neither should be regarded as the actual cause of clinical
symptoms, but a raised level of either
evidences a grave state of affairs in the
respective organ. When a patient dies in
hepatic coma, there are many other factors which might have contributed to the
changes in consciousness and to death:
electrolyte disturbances, bile nephrosis,
severe respiratory ·infections, septicemia,
etc.
Methods have been devised to induce
hepatic failure and coma in dogs on the
basis of ischemic necrosis of the liver by
means of the formation of Eck fistula
and subsequent ligation of the hepatic
artery. Antibiotics were administered to
reduce the bacterial factor. Though the
clinical picture of this experimental coma
resembles that of man, one cannot draw
the conclusion that the mechanisms involved are the same. Rappaport and his
group of workers postulate on the basis
of these experiments that circulatory factors may be responsible for the onset of
and relief of hepatic coma. They maintain that the onset of liver failure is preceded by acute degeneration and swelling
of liver cells which compress the blood
vessels producing ischemic necrosis, the
latter giving rise to some toxic substance
which may affect the brain cells. According to Rappaport, hepatic ischemia is the
factor responsible for coma following surgical procedures to relieve portal hypertension in cirrhotic patients. Due to
cirrhosis most of the portal blood is
shunted into the systemic circulation producing extrahepatic, and perhaps intrahepatic, Eck fistulas. When the surgeon
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ligates the hepatic artery he simulates the
experimental hepatic necrosis produced
in dogs.
Widespread destruction of the hepatic
parenchyma is also associated with a general reduction of the multiple hepatic
functions, and more than once it has been
said that multiple disturbances of liver
function should be considered the cause
of liver coma rather than one single
factor.
PRINCIPLES OF MANAGEMENT
Prevention
It is difficult to speak of prevention of
a condition the causative factors of which
are not known. In a broad sense the ultimate goal would be the prevention of
liver disease in general.
It would, however, seem wise to avoid
those factors which are known to play a
role in precipitating coma in cases of liver
disease. Schwartz has described one patient in whom the rise of dietary protein
intake from 50 to 75 grams daily was
sufficient to induce hepatic coma, and
protein restriction resulted in reversal of
clinical symptoms and reversal of electroencephalographic pattern to normal. Nutritious diets consisting of large amounts
of protein and carbohydrate are usually
given to patients with cirrhosis, but
when impending coma is suspected protein should be restricted. Each patient's
tolerance for protein should be individually evaluated. Ammonia- containing
compounds for inducing diuresis or other
purposes should be avoided.

As the patient may be delirious, restless, and hallucinated in the early stages
of impending coma, sedation may seem
indicated, but it is known that morphine,
demerol, barbiturates, and paraldehyde
can precipitate coma. If sedatives are used
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their potential dangers should be borne
in mind.

tion of breakdown of carbohydrate metabolism with its associated enzyme systems.

Although electrolyte disturbances do
not seem to play a causative role in pathogenesis, still they may contribute to the
severity of the illness and, therefore,
should be corrected if abnormal. Frequent
paracenteses should be avoided . If done,
one must realize the changes in electrolyte concentration which they cause.

Attention has been drawn to the fact
that large amounts of glucose and water,
if other electrolytes are not corrected, may
be harmful. This has even been implicated as a factor in causing the so-called
hepatorenal syndrome. Some authors include under this syndrome those cases
where hepatic coma is associated with
oliguria or anuria.

To avoid hemorrhages an attempt
should be made to correct the prothrombin level by parenteral vitamin K administration. However, the response is rarely
satisfactory because of the severe liver
damage.

Latner developed more elaborate infusions of glucose-saline, plasma, and vitamins which he claimed reduced the mortality rate to only 10-20% . He also used
penicillin to reduce infections.

Infections, anoxia, and shock should be
avoided .

The form and amount of glucose used
depends on clinical judgement.

Impending or Deep Coma

(b) Antibiotics

It has been said that one should be a
persistent optimist while treating patients
with hepatic coma as this is a reversible
condition. But this same reversibility
makes it difficult for one to evaluate the
results of all the treatment schedules
which have been claimed successful in
reversing coma. One cannot know which
cases would recover without any treatment at all. Also the diversity of the
underlying disease conditions on which
coma may be superimposed and the unknown etiological factors add to the complexity of the problem.

Aureomycin in doses of 1 gram daily
by stomach tube has been advised both
because of its antibacterial action and because of the role it may play in preventing hepatic necrosis. Death from hepatic
necrosis in experimental animals can be
prevented by giving aureomycin. It has
been said that this dosage is lower than
that ·which would cause fatty infiltration
of the liver and negative nitrogen balance.

(a) Glttcose, Vitamins, and Electrolytes
Large amounts of intravenous glucose
have been rather universally used as was
recommended by Butt and Snell. They
gave the daily amount of 3000 to 4000
cc. containing 50 to 100 mgm. of thiamine hydrochloride and 250 to 500 mgm .
of nicotinic acid. This treatment schedule
was devised empirically on the assumpMAY, 1955

If intravenous therapy is required, the
intravenous dose of aureomycin should be
limited to 40 mgm. per kilo of body
weight per 24 hours.
Larger doses than those mentioned may
be used when the potential dangers of an
excessive dose are outweighed by the
g ravity of the illness.
(c) Hormones
ACTH and cortisone have been advocated. Ducci and Katz noted a spectacular response to cortisone plus aureomycin
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and/or intravenous terramycin in two
young patients who had been in coma for
over two days. They state that due to
the prevalence of acute hepatitis in Chile
they have had a large experience with
this disease, and in more than a thousand
cases they had not seen a recovery after
coma before. They used very high initial
doses of intramuscular cortisone. In one
of these patients they used 1500 mgm
on the first day and 300, 250, and 500
mgm on the consecutive days; thereafter
the dose of 100 mgm was used and gradually reduced .
Others have not met with Ducci's success using cortisone, although they followed his regime. As in many other 'diseases in which cortisone and ACTH have
been tried, the results are conflicting.
Bleeding episodes and water retention
have been reported after ACTH administration . It has also been mentioned that
ACTH increases blood ammonia.
The use of cortisone and/or .A.CTH
seems to be ill advised, especially when
one takes into consideration the reported
relapse rate as high as 25 %, frequency of
side reactions, and fai lure in preventing
chronic hepatitis.

(d) Glutamic Acid

Walshe (1953) used sodium gluamate
intravenously on the basis of theories as
outlined previously in five episodes of
coma in three patients with subacute or
chronic liver disease. Consciousness returned on all occasions except one when
glutamate was used together with ammonia ion exchange resin. In one case
when glutamate was discontinued, the patient relapsed into coma which deepened
on glucose administration, but when glutamate was readministered he regained consciousness. W oodraw has reported success with glutamate, also in virus hepatitis complicated by coma.
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Though this type of treatment looks
very promising, it has not been successful in every case. Riddell and McDermott
(1954) treated 11 patients, six of whom
improved on treatment. Three of these
six recovered from hepatic coma, but only
one of these left hospital. Two others
died of intercurrent diseases. Blood ammonia level fell after administration of
glutamate in seven patients studied. In
four of these cases the decrease of blood
ammonia level resulted in clinical improvement. In one case it was shown
that improvement was only temporary,
and blood ammonia level became less responsive to sodium glutamate as the patient's condition grew worse.
The value of glutamic acid treatment
has not yet been established. Riddell
points out that in patients with terminal
hepatic failure one cannot expect much
more than temporary improvement despite
any treatment used. More success may
be expected in those cases where the underlying liver disease is not so severe.
(e) Additional Measttres

Blood loss should be replaced in cases
of hemorrhage. As experimental studies
suggest that oxygen is essential in prevention of further liver damage, it should be
given. Parenteral vitamin B and K administration has been recommended. Some
have used crude liver extract in addition
to vitamin B.
(f) Surgical Treatment

There is little reference to a surgical
attack on this condition in the literature.
Rappaport describes twelve patients suffering from acute yellow atrophy with
impending coma Pribram and Upham reported, eight of whom recovered within
twenty-four hours after bile drainage.
Rappaport, being an exponent of the vascular theory, explains that on removal of
the stagnant bile the intrahepatic pressure
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was decreased and blood flow improved.
The same authors have reported improvement in fourteen cases treated by sympathetic block between the eleventh and
twelfth dorsal vertebrae. The beneficial
effects were ascribed to the release of
arterial spasm which impaired the hepatic
circulation. Periarterial neurectomy has
been performed in 17 cases of chronic
hepatitis with apparently good results.

Summary
In summary, the management which has
proven to be of some value and worth
clinical trial in patients suffering from
hepatic coma is as follows: intravenous
glucose, vitamins B and K, correction of
electrolyte disturbances, aureomycin, sodium glutamate, blood transfusions, and
oxygen.
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together with highly suggestive symptoms, signs, laboratory data, and suggestions for further investigation to ascertain the diagnosis.
As D r. Hyman states in the preface,
" devised as a complement to, rather t_han
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Severe Infantile Diarrhea
Alan Rundle, M.D.

INTRODUCTION
Fluid and electrolyte loss in an infant can be of sucb severity that their
restoration to normal often precludes specific therapy in importance. The explanation for this fact lies in the immaturity of renal function and other regulatory mech anisms for the maintenance of body fluids. The normal requirements for
infants of water, electrolytes, pro tein, calories, and vitamines are relatively greater
than in adu lts.

CLINICAL ASSESSMENI'
A. Dehydration

(1)
(2)
(3)
( 4)
(5)

sunken fontanelles
sunken eyes
soft eyeballs
dry mouth and skin
loss of skin turgor and elasticity

B. Acidosis

(1) signs of dehydration
(2) acetone odour on breath
(3) respirations deep and sighing,
or may be shallow
( 4) lethargic or restless
( 5) extremities cold and cyanotic
(shock)

The most important, and often ignored,
factor in taking the history is the amount
of fluid lost. Several small stools may not
be significant, whereas a few large watery
stools are a danger sign.
Dehydration can be very deceiving. A
child that has been in a good state of
nutrition prior to illness may not show
the characteristic signs, but still be seriously dehydrated and even in acidosis.
Conversely, a child in a poor state of
nutrition prior to illness will more readily
and more rapidly demonstrate the classical
signs and symptoms.
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LABORATORY ASSESSMENf
If laboratory procedures are available
the C0 2 combining power should be estimated on admission. This test may be
repeated after star.ting corrective therapy
to avoid precipitation of an alkalosis and
to determine the progress of treatment.

After hydration has been established
the blood electrolytes should be determined. Particular attention should be
placed to the potassium level. This is
especially important if the replacement
fluids do not contain that electrolyte.

EFFECTS OF ELECTROLYfE
IMBALANCE
Hypokalemia (low potassium) may be
manifested by weakness, silent distention
of the abdomen, dyspnea and cardiac
signs, including cardiac arrhythmias and
cardiac failure. Unless care is exercised to
see that potassium is given this state may
be precipitated. Potassium may be administered intravenously in Ringerlactate solution or in fresh whole blood, or orally
in potassium chloride. The usual, and
safe dosage of potassium in infants is 3
milliequivalents per kilogram per day.
H yperkalemia, a rare occurrence, may be
precipitated by continued administration
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of potassium in the face of poor renal
function or by giving stored bank blood.
Potassium levels may become very high
if blood is stored for a long time due to
cellular release of ionized potassium.

to accomplish this stage. This solution
provides water to increase the blood volume, electrolytes for deficit repair, and
lactate which spares protein and prevents
further ketosis.

H yponatremia may follow the rapid loss
of salft if non-electrolyte replacement
fluids are used primarily. The signs and
symptoms in this condition are apathy,
tachycardia, hypotension, weakness, and
muscle cramps.

Approximately 10 c.c. of Ringer-lactate
per pound body weight may be given at
a rapid rate.

H ypernatremia may exist prior to hydration due to hemoconcentration. This is
generally changed into a mild hyponatremia with hydration.

ROUTE OF REPLACEMENT FLUIDS
In severe dehydration, with or without
accompanying acidosis, intravenous replacement therapy is imperative. Oral
feedings may be continued, but care
should be exercised to avoid water
intoxication.
Interstitial therapy is contra-indicated
since the sluggish circulation of the infant
will not absorb the fluid readily. Furthermore, if non-electrolyte solutions are given
interstitially they will further deplete the
blood electrolytes by osmosis.

Contra-indicated fluids are:
(1) Whole blood-may cause heart
failure because of addition of a concentrated solution to an already concentrated
fluid.
(2) Non-electric solutions - decrease
blood electrolyte levels with hydration.

Stage II

On entering this stage a complete
assessment of the blood should be done.
Before instituting treatment with alkalis
adequate renal function should be established.
Various rules are used for determining
the amount of 1/6 Molar sodium lactate
to use such as:
(1) (60 -

C02 C.P.) x 0.8 x lb wt

= c.c. needed.
2

(2) 4.2 c.c. 1/6 molar lactate per kilogram of body weight to raise the
C0 2 content per Milliequivalent
per litre.

TREATMENI'

A. Treatment of Dehydration
and Acidosis

There are two stages:
(1) establishment of normal blood

volume and renal function
(2) electrolyte

replacement
correction of acidosis

and

Stage I

Ringer-lactate solution is ideally suited
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The acidosis should be corrected to
about 18 mEq. and only in increments of
10 mEq. at a time. Following this therapy any existing electrolyte deficit may
be corrected by giving additional Ringerlactate, whole blood, or specific oral replacement. Fresh whole blood has the advantage of replacing electrolytes, correcting any existing anemia, and providing
proteins.
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--....,Severe Infantile Diarrhea-------------Total fluids for the first 24 hours
should be in the range of 75-100 c.c. per
pound body weight. This total may be
reached by giving 5% glucose in distilled
water in addition to the previous fluids.
After the first 24 hours 40-50 c.c. of
fluid per lb. body weight should be
given as :
(1) Ringer-lactate - 10 c.c. per lb.
body wt. per 24 hrs.
(2) 5% glucose in D/W - 30-40 c.c.
per lb. body wt. per 24 hrs.

(3) whole blood and oral feedingssubtract amount given from 5%
glucose in D/W.
B. Medication and

(1) Medication -

o,.aJ

Feeding

Appropriate medica-

CLINICAL NEUROLOGY
F. A. Davis Co., Philadelphia.
This third edition of the author's text
contains revised information on several
topics. Poliomyelitis, aneurysm, meningitis, neurosyphilis, epilepsy and encephalitis are but a few of the topics which
have been rewritten and brought up to
date.
Dr. Alper presents concise, detailed information in a manner which is dear and
readily assimilated. The initial three chapters of the book deal with the examination of the central nervous system, the
interpretation signs and symptoms and
the diagnosis of the nervous system disease. A host of topics are discussed in
subsequent chapters. These topics include headache, vertigo, coma and pain;
neuritis and neuralgia; diseases of the
82

tion should be given to combat the
causative factor.
(2) Oral Feeding-Oral feedings may
be discontinued during the first
12-48 hours, but continued lack of
of oral feeding will result in starvation of the infant.

If oral feedings are given at the
onset it is wise to start each with
small quantities of Ringer-lactate
or glucose water solutions, increasing the feedings as the diarrhea
improves.

Finally, the child may be started
on protein milk (3 ounces per lb.
body wt.) and the intravenous
discontinued.

meninges; vascular diseases of the brain;
cranial trauma; tumours; abscesses of the
brain; extrapyramidal disease; multiple
sclerosis; intoxication and injuries by
physical agents; vegetative nervous system and endocrine disorders; nuclear
amyotrophies and myopathies; degenerative diseases; congenital and development
disorders ; diseases of the skulf and
vertebrae.
The various diseases are discussed under the headings of etiology, symptoms,
diagnosis and treatment. The written
script is illustrated with photographs of
lesions and clinical cases, numerous diagrams and tables of differential diagnosis which contribute much to the text.
This is an excellent book which should
be of interest to students and practitioners
alike.
-David Lawson, '57
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Boeck's Sarcoid
Stanley Iwan. '55

Boeck's Sarcoid is first introduced to the student of clinical medicine in the
differential diagnosis of respiratory, neurological or other clinical disease entities.
The discussion terminates here, however, and nothing further is mentioned about
this dise.ase because it appears far down on the list of differe.n tial diagnoses, and
until recently has been considered a rare clinical entity.
To discuss fully the subject of Sarcoidosis is beyond the scope of this paper,
as· new concepts about the etiology, diagnosis and treatment of the disease are
now rapidly being published. An attempt will be made, however, to outline some
of the main features of the disease and to present a review of some of the more
recent literature.
Historically, the first case was reported by Jonothan Hutchinson in 1875.
In 1889 Besnier described a case in which the patient had violaceous swellings
on the nose, ears and areas about the interphalan~eal joints. He termed this condition "Lupus pernio". About the same time Boeck described a case of generalized lymphadenopathy and he titled the disease "Multiple Benign Sarcoid of
the Skin", presumably because the histology resembled that of sarcoma.
In 1914 Schaumann first described the disease as a distinct clinical entity
and linked the previous descriptions of Boeck and Besnier together as a specific
disease. In 1920 Jungling emphasized the typical bone lesions and feeling that
they were tuberculous in nature, caiJed the disease "Osteitis Tuberculosa Multiplex Cystia". Prior to this, in 1909, Heerfordt described the syndrome of uveoparotid fever and it was not until twenty-five years later that Bruins Slot in
Scandinavia, Poutrier in France, and Longscope and Pierson in the United States
recognized and proved this to be a unique manifestation of Sarcoidosis. The
disease is now variably titled, the two most common names used being Boeck's
Sarcoid and Sarcoidosis.

DEFINITION
The definition of Sarcoidosis as set
forth in the Conference on Sarcoid by the
U.S. National Research Council in 1949
serves to illustrate how little is actually
known about the condition. By definition, Sarcoidosis is a disease of unknowu
etiology. Pathologically it is characterized
by the presence in any organ or tissue of
epithelioid cell tubercles with inconspicuous or no necrosis and by the frequent
presence of refractile or apparently calcified bodies in the giant cells of the
tubercles. The characteristic lesion may
be replaced by fibrosis, hyalinization or
both. Clinically, the lesions may be widely disseminated. The tissues most frequently involved are lymph nodes, lungs,
skin, eyes and bones particularly of the
extremities. The clinical course usually is
chronic with minimal or no constitutional
symptoms. However, there may be acute
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phases characterized by a general reaction
with malaise and fever or there may be
signs and symptoms referable to the tissues and organs involved. The intracutaneous tuberculin test is frequently
negative; the plasma globulins are often
increased. The outcome may be clinical
recovery with radiographic evidence of
residue or impairment of function of
organs involved, or a continued chronic
course of the disease.
INCIDENCE
General-Hodgson and Woolner of the
Mayo Clinic feel sarcoidosis is probably
far more common than is generally suspected. Schonholzer, in 1947, reported
the incidence of sarcoidosis in the Swiss
Army as being 13 per 100,000, while in
the same year Ross-Smith reported the incidence in Oxfordshire as being 0.66 per
100,000 population. Michael, Cole et al
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---Boeck's Sarcoi:a-------------------in a survey of the U .S. Army reported
the incidence of sarcoidosis as being 0.88
per 100,000 in white soldiers and 17.81
per 100,000 in Negro soldiers.
Age-Sarcoidosis occurs predominantly
in the 20-40 year age group but can occur
at any age. The youngest case reported
was in a four month old child, while several other cases in children under 15
years of age have been reported. The disease has been found in people over 70
years of age.

Race-In the American series, some authors report as high as 86% of cases
occurring in the Negro. Conversely,
Scandinavian authors report a predominantly white involvement. Hence all
races may be affected, with a higher incidence in the Negro.
Geography-Sarcoidosis is world-wide in
distribution and all strata of society are
affected, although the lower income
groups predominate. In a World War II
Survey, Cone noted that a heavy concentration of his 350 cases was in the southeastern portion of the country and were
mostly rural. Other authors have also
noted a preponderance of cases coming
from rural districts.
ETIOLOGY
Although there are cases where more
than one member of a family has had
sarcoidosis there is no indication of a
familial or inherited tendency towards the
disease. Similarly there is little to suggest a link with occupation. Proof of the
statement that the true etiology of sarcoid
is unknown is reflected by the large number of etiological concepts put forth, each
of which has its own group of proponents. The following concepts are discussed briefly and their popularity commented upon.

Bacterial Theories

Brucellosis- The Brucella organism was
once implicated as a cause, but the
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Brucellergen test is negative in sarcoidosis. Michelson, after a careful study of
eight classical cases of sarcoidosis stated
that there was no connection with
Brucella.

Treponema Pallidum - The absence of
postive serologic reactions and the failure to elicit a history of contact are
strong arguments against this theory. Further contra evidence exists in the difference in histological appearance of the two
granulomata as well as the absence of
Treponemes in the sarcoid lesions.
M ycobacterium Leprae--Sarcoid patients
have been tested for the lepromin reaction but only slight or infrequent reactions have occurred and there is no indication that sarcoidosis is an atypical
tuberculoid leprosy. Some authors suggest it may be a pleomorphic form between tuberculosis and leprosy, but this
is doubtful because of the geographic distribution, incidence and the lack of intrinsic organisms in sarcoidosis.
Mycobacterium Tuberculosis-For years
arguments have raged between the supporters of an anergic tuberculous reaction
and the faction claiming that tuberculosis
was in no way associated with the cause
of sarcoidosis. The following points have
been brought out and discussed:
Histologic Appearance-Caseation is absent or extremely rare in sarcoidosis,
while it is quite common in tuberculosis.
Fibrinoid degeneration occurs more commonly in sarcoidosis than in tuberculosis.
The sarcoid giant cell differs slightly
from the tuberculous type. On silver staining a fine reticulum is present in sarcoidosis, but this also occurs in noncaseating tuberculosis. No definite proof
of the cause of sarcoidosis can be determined by histological appearance however, since syphilis, leprosy, typhoid, brucella, tularemia and other granulomatous
diseases give a very similar picture.
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Presence or Absence of Mycobacterium
Tubermlosis- Tbe tubercle bacillus is absent in the authentic cases of sarcoidosis.
If it is present, it is there as a secondary
invader or a dubious diagnosis of sarcoidosis has been made. Kyrle states that
the foreign body type response seen in
sarcoidosis and that seen in response to
the disintegration products of tubercle
bacilli are the same and he postulates that
organisms are present in the early lesion
and then disappear. However, the correlation between finding tubercle bacilli and
sarcoidosis together is that of random
chance, or no greater than that of finding the co-existence of tuberculosis and
Hodgkins Disease.
Results of Tuberculin Skin Test-In sarcoidosis, the intracutaneous test is usually
negative even when a dose of 1 mgm. of
old tuberculin has been used. 76.4 % of
the general population and 80-85% of
special population groups, i.e. doctors,
nurses, etc., react to the tuberculin test
while only 5-35 % of sarcoids show a
positive tuberculin reaction. This latter
figure varies with the individual series.
The lack of response is attributed to
anergy and is rarely reversed if the sarcoid patient is vaccinated with B.C.G.
A ssociati011 of Tuberculosis and SarcoidSarcoidosis terminates in tuberculosis in
10-25 % of cases only, suggesting that the
tubercle bac;illus when found is a secondary invader in a previous disease process.
Serological Studies-By using the highly
sensitive complement fixation test, it was
shown that only 27 % of sarcoid patients
had tuberculous antibodies while 62% of
tuberculous patients had these same antibodies.
Age-The incidence of tuberculosis increases with age as is demonstrated by
skin testing, case histories and X-ray surveys. Sarcoidosis, however, is most promi-
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nent in the 20-40 year age group with
only rare cases being reported in the extremes of life when tuberculosis is quite
common.

Organs Involved-The organs involved
in the two diseases are much the same
in some instanc;es, e.g. lungs, spleen, liver,
lymph nodes and bone marrow. Sarcoidosis has, however, a much higher incidence of uveal, parotid and myocardial
involvement. Rich has pointed out that
sarcoid can pepper the lungs and not involve the spleen and liver, a condition
never seen in tuberculosis.
By using eighteen mycobacterial tuberculins and one control preparation in
seven sarcoids and five healthy controls,
it was noted by Brooke and Day that
there was no significant difference in the
response of the two groups. Hence this
was considered evidence against tuberculous causation.
The tuberculous theory of causation
has been argued for many years with no
significant advance being made by either
side. Many authors, including Longcope,
now feel that new fields must be explored
before the cause of sarcoidosis will be
found.

Parasitic and Protozoal Theories

Leishmaniasis - This condition gives a
similar histological appearance to sarcoidosis and also a hyperproteinemia, but
the geographic distribution and lack of
proof of the presence of intracellular organisms rule against it.
Helminths-In 1952 Jaques described a
case in which larvae of Strongyloides
stercoralis were found in the patient's
peroneal tissues. On histological examination he showed a Schaumann body ·being formed from this larva and it is well
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---Boeck's S a r c o i a - - - - - - - - - - - - - - - - - - - known that Schaumann bodies do occur
in sarcoid giant cells. Jaques found three
other cases in which Nematodes were implicated and he feels more conclusive
proof could be obtained if stool examinations for parasitic ova and larvae were
carried out on sarcoid patients. He also
feels that the geographic distribution, the
epidemiology, the racial predilection, the
organs involved and the results of laboratory studies show a good correlation between sarcoidosis and Nematode infestations.
It bas also been shown experimentally
in guinea pigs that the histological response to various antigenic principles of
Nematodes is granulomatous and that no
close association with the larva itself is
necessary to produce the granuloma.

merous other authors have made viral
type suspensions and used them t o get a
similar positive skin reaction. However,
the Frei test was negative in sarcoid patients and this was felt to cast some doubt
on viral etiology.

Beryllium
Higgins tn 1947 described 3~ cases
of pulmonary sarcoidosis, 30 of whom
worked in one plant. All but two of the
3~ were engaged in the manufacture of
fluorescent lamps. Other writers have
also suggested the close association of
chronic beryllium granulomatosis and sarcoidosis but the evidence so far accumulated is inconclusive.

Foreign Bodies
Fungi
Many Scandinavian authors stressed the
relationship between sarcoidosis and streptothrix, especially in regard to tonsillar
lesions. Streptothrix is so common a
contaminant that it is unlikely that it
plays any part in causing sarcoidosis.
Longcope and Pierson failed to grow
fungi from sarcoid lesions on Sabouraud's
medium. Agglutination by several fungal
sera and complement fixation were absent in seven cases of sarcoidosis reported
by Harrell.

Virus
In 1932 Kissmeyer prepared an antigen from a cutaneous lesion of sarcoidosis
which led to a specific skin reaction. The
mode of preparation suggested the presence of a virus.
Kveim's antigenic test solution was prepared in a similar manner and the response to it was interpreted as a specific
allergic reaction to a specific virus. Nu-
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Revfem, using polarized light, examined
1000 cases of sarcoidosis. A few specimens contained refractile material (in one
case calcareous spar) which Revfem felt
might be responsible for a limited number of cases of sarcoidosis
Calcareous spar is found in the soil
of Cambrosilurian regions and sarcoidosis
is more prevalent in rural areas, especially among farmers and gardeners. An
air borne dust (a few microns in size)
could enter the blood stream and lymphatics to produce a generalized disease.
The material might be removed, dissolved
or converted into amorphous, non-injurious compounds.

Neoplasm
In this etiological concept, sarcoidosis
is compared to the lymphomata and
Hodgkin's Disease. In 19~0 Gherardi presented a case of common hepatic duct
carcinoma in which examination of a
regional node revealed confluent granu-
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lomata of sarcoidosis. No other granulomata were found at autopsy, and it was
felt this was a local rather than a generalized form of the disease.
Many similar cases have been presented
in the literature, with the difference being that the primary tumor was in breast,
lung, thyroid and many other organs.

PATHOLOGY
Sarcoidosis is a generalized systemic
condition capable of involving every
organ in the body. The disease is characterized by round circumscribed masses
resembling miliary tubercles composed of
focal areas of large mononuclear cells of
epithelioid structure, and occasional multinucleated giant cells. The epithelioid
cells often give the impression of being
larger and having more nuclei which are
often distributed evenly through the cell
rather than having a peripheral or polar
arrangement as is the picture in tuberculous epithelioid cells. Neutrophilic leukocytes and caseous necrosis are usually absent. Reticulin fibres are demonstrable intact throughout the nodule, in contrast to
the breakdown and disappearance of these
fibres in caseous tuberculous lesions.
A few lymphocytes may be present in
and around the focal lesion, but usually
are less numerous than in tuberculous
lesions. The focal lesions of sarcoid tend
to be sharply circumscribed and are separated from the surrounding tissues which
appear normal and show no evidence of
inflammatory reaction. On silver staining, however, a delicate reticulum between granulomata is revealed.
Various types of inclusions have been
found in the giant cells. These include
"spiculated bodies" or "asteroid bodies".
The asteroid body is chemically stable but
is not pathognomonic of sarcoid lesions
MAY,
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since it is found in giant cells of other
granulomatous lesions.
Another inclusion commonly found is
the Schaumann Body which is variable in
size. It is a round or oval, non-crystalline, laminated, doubly refractile body
with a two-layered membrane. This body
may frequently fill a giant cell or burst
out and lie in the intracellular spaces. It
is not acid-fast. This body is also nonspecific since it can occur in leprosy,
tuberculosis and lupus erythematosus.
Jaques, however, relies heavily on the
Schaumann body to substantiate the Nematode theory of causation.
Other inclusion bodies found in the
giant cells are spindle-haped, radial or
irregular and may give staining reactions
characteristic of elastic tissue, calcium or
iron.
Hannesson described an early " presarcoid" lesion of lymph nodes consisting of
a non-specific proliferation of the littoral
sinusoidal reticulo - endothelium which
choked the lymphatic sinusoids. An early
granuloma occurs in juxtaposition to such
a sinusoid.
The granulomas all appear at the same
stage of development but heal in various
fashions and rates. For rigid diagnosis,
no caseation should be present, but Hodgson and W oolner feel that small foci of
caseous necrosis with the absence of
Tubercle Bacilli are compatible with the
diagnosis of sarcoid. Fibrinoid necrosis
can occur in any of these granulomata.
Healing in sarcoidosis occurs by progressive fibrosis and hyalinization without calcification. The lesions are replaced
with a cellular whorled collagen and may
give an amyloid staining reaction (paramyloidosis) with eventual conversion into
small sclerotic nodules.
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- - -.Boeck's Sarcoia--------------------To facilitate an appreciation of the presenting clinical symptoms, a discussion of
the organs involved and the incidence of
this type of presentation will be mentioned . A description of some of the
more salient clinical pathological features
is also included.

cases and is more commonly seen in the
Negro. The skin lesions are of three
types:
1. Small, discrete, elevated nodules which

appear on the face about the eyelids,
nares and ears. These lesions are
small, elevated, pitted or umbilicated
and may be yellow or purple in colour.

Lymphatic Involvement
Superficial and deep nodes are involved
in 87% of cases of sarcoidosis, while
Boyd claims that the deep nodes alone
are affected in 75% of cases. Lymphadenopathy, either generalized or localized, is the most frequent presenting sign.

2.

Large nodules or masses which involve the subcutaneous tissues and are
smooth and purple, occurring about
the nose and joints. These are the
lesions named "Lupus Pernio" by
Besnier in 1889.

Pulmonary Involvement

3. Large flat plaques, finely granular or
scaly which cover large patches of the
skin.

The lungs are involved in 76-90% of
cases and a variety of lesions appear on
radiological and postmortem examination.
The lesions occur predominantly in the
glands draining the lungs and/or in the
lymphatic channels and interstitial tissues of the lung parenchyma. The pulmonary lesions are of the following types:

The skin lesions cause varying degrees
of tissue distortion. In no case reported
was the skin involvement present without evidence of other organs being involved by the sarcoid lesions.

Cardiac Involvement
1. Bilateral, symmetrical involvement of

the hilar and bronchial nodes without
evidence of parenchymal infiltration.
2. Mediastinal node involvement with
varying degrees of parenchymal infiltration .
3. Parenchymal lesions resembling miliary T.B.
4. Discrete nodular infiltration of the
parenchyma with or without hilar node
involvement.
5. A diffuse or confluent parenchymal
infiltration.
6. Parenchymal involvement, with pleural
involvement is very rare.
Skin Involvement

Skin involvement occurs in 27-30% of
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Sarcoidosis can involve all three layers of the heart, and cardiac involvement
is present in up to 20 % of diagnosed
cases. Galveson was the first to note abnormal ECG changes which included
heart block and cardiac arrhythmias all
of which were refractive to the usual
methods of therapy. Boyd has seen two
cases of severe cardiac involvement which
caused the patients' death. Several other
similar cases are reported in the literature.

The Spleen
The spleen on pathological examination is the second most frequently involved
organ, but clinically splenomegaly is very
rare. One case of a ruptured spleen involved by sarcoidosis has been reported.
The C.N.S.
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Colover, in a series of 115 cases, noted
that the facial nerve was involved in 50%
of cases. The optic, auditory and glossopharyngeal nerves are also involved, but
far less frequently. Sarcoidosis may involve the brain itself as well as the meninges and thus be a direct cause of death.
The patient will present to the neurologist
signs and symptoms relative to the area
of the brain involved.

Eyes a11d Uveoparotid Fever
Longcope states that 22% of his series
of 607 cases had ocular involvement of
some type or other. The Negro is more
frequently affected and the lesions may
be a granular uveitis which is most common, but iritis also does occur. Any part
of the eye may be affected, and nodules
on the eyelids are considered diagnostic
of sarcoidosis by Harrell and Friedman.
The lesions usually regress and heal, leaving partially impaired vision, but may
progress to glaucoma and cataracts in the
end stages.
Uveoparotid fever is seen usually in the
second and third decades. Paresis of the
facial nerve follows the prodromal symptoms of lassitude, general malaise and
fever, etc., and soon the parotid swells.
Uveitis always occurs, and other ocular
lesions may be present. The facial nerve
paresis clears rapidly; the fever lasts weeks
or months; the parotid swelling may last
even longer. The ocular lesions regress
slowly with considerable scarring and impairment of vision.

Digestive System
The liver is predominantly and most
frequently involved, but only rare cases
of liver dysfunction have been reported.
The portal areas are commonly involved.
The occasional American centre advocates
the use of liver biopsy in diagnosis.
Rare stomach involvement may simulate a gastric ulcer, but diagnosis can only
MAY, 1955

be made by examination of the tissue.
Wilson et al felt sarcoidosis was the cause
of regional ileitis, but Snapper and Pimpen feel strongly that there is no relationship between the two diseases.

Bone Marrow
Katz and others feel that 10-20% of
sarcoidosis involves the phalanges, metacarpals and metartarsals. The bone lesions
are solid and start in the same marrow.
Histologic proof of the nature of the
osseous lesions is less common than the
literature leads one to believe because bone
marrow biopsies are infrequently done.
Despite the invasion of bone marrow,
anemia is a very rare complication of
sarcoidosis.

Miscellaneo11s
Other organs rarely involved include
the kidney, bladder, pituitary and thyroid.
Boyd reports two cases of diabetes insipidus because of pituitary involvement.
Kidney involvement may precipitate mild
kidney failure, and in one case hypercalcemia due to sarcoidosis was discovered
when repeated rapidly forming kidney
stones were noted.

DIAGNOSIS
Because of its lack of specificity and
its protean manifestations, a diagnosis of
sarcoidosis is difficult, and is infrequently made. Many cases are picked up by
chance examination, and on thorough
questioning of the patient no history or
complaints of any nature can be elicited.
Many cases may present with very vague
and minor symptoms and then dear spontaneously with time, with no therapy and
no adequate diagnosis having been made.
Sarcoidosis per se infrequently causes
death. Death results usually from complications of the original disease process.
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---Boeck's S a r c o i a - - - - - - - - - - - - - - - - - - Because of the multiplicity of organ involvement the sarcoid patient may present himself at the office of an ophthalmologist neurologist, interrist or dermatologist, each of whom can make the
diagnosis on the presenting symptoms.
(The presenting symptoms are primarily
those of the organ system most seriously
involved.) The general clinical manifestations of the disease in order of their
decreasing frequency are:
1. lymphadenopathy
2. dyspnea

3. skin eruptions (lupus pernio)
4. weight loss
5. expectoration
6. fatigue and malaise
7. fever
8. anorexia
9. chest pain
Other associated presenting symptoms
may include parotid swelling, joint pains,
swelling of the hands and feet, abdominal
pains or masses, hoarseness, nausea and
vomiting and various neurological manifestations.
The symptoms noted above and their
relative frequen cy of occurrence were
classified by Longcope in a series of 494
cases. In this same series 13.5 % of patients were completely asymptomatic.
The syndrome of uveitis, parotitis and
facial nerve palsy first described by Heerfordt in 1909, has allowed the astute
clinician to diagnose sarcoidosis on a
number of occasions on clinical grounds
alone.
Laboratory Findings
Urine-Urinalysis is usually normal, but
occasionally Bence-Jones proteinuria has
been observed. even in the absence of bone
lesions.
Blood-Sarcoidosis is rarely accompanied
by a slight microcytic anemia. The leucocyte count is variable. If a leucopenia
exists, then some authors feel that the
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spleen is involved. The leucopenia is
predominantly a neutropenia; but in most
cases there is an accompanying peripheral
eosinophilia which some authors use as
an index of disease activity. This view
is not universally supported .
In nearly every series of cases, the
E.S.R. was elevated, with values as high
as 100 roms/ hr. being noted in a large
proportion of cases.
Serum Proteim-The serum proteins are
nearly always elevated, with the total protein going as high as 9 gm/ 100 cc. This
total is made up of a mild hypoalbuminemia and a fairly marked hyperglobulinemia with an accompanying reversal of
the A./ G ratio.

A. serum hypercalcemia with a normal
or elevated serum phosphorus has been
reported . In most of these cases, however, there was an associated elevation of
the serum alkaline phosphatase.
Miscellaneous findings consist of a normal or slightly depressed serum cholesterol and occasionally impaired liver function tests and abnormal bilirubin excretion . (These findings are more prone to
occur if the liver involvement is very
severe.)
Because of the wide variation in symptoms and ordinary laboratory findings
the slightest clinical suspicion of sarcoidosis should be followed by other diagnostic aids, which include:
1. Radiography
2. ,Bronchoscopy
3. Biopsy

4. Bacteriological studies
5. Kveim-Nickerson Skin test
RAdiography--Otest radiography is extremely useful in picking up sarcoidosis
in its early stages. The chance finding of
chest involvement on routine chest X-ray
leads to further examination of the patient" and thereby allows the clinician
to discover the disease. Mclaughlin
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gives a simplified description of the
types of lung involvement seen in chest
radiography:

ingly, because of its complications. Cases
are reported where thoracotomy was performed in order to make a diagnosis.

1. a diffuse, disseminated, nodular type
of disease which is radiologically indistinguishable from miliary tuberculosis.

Bacteriological Studies - Bacteriological
studies are negative methods of diagnosis,
since with the existing etiological concepts, the presence of any bacteria negates
a diagnosis of sarcoidosis, unless the bacteria are present as secondary invaders.
The studies necessary are those routinely
used to culture bacterial flora as well as
specific methods to culture the tubercle
bacillus and the various fungi. Once
these methods show no growth, the diagnosis of sarcoidosis is plausible.

2. diffuse or localized changes of a
linear or strand-like character, which apparently follow the distribution of the
bronchovascular ramifications and give
prominent root trunks and peripheral
markings.

3. patchy, coalescent densities having
the appearance of conglomerate fibrotic
induration, usually diffuse and particularly pronounced in the mid zone and
basal portions.
In association with the lung findings,
the Mayo Clinic reports 15-20% of patients show radiographic bone involvement. The lesions see.n are round, solid
areas occurring primarily in the small
bones of the hands and feet. Because of
the small number of patients who have
skeletal studies done, the percentage of
bone involvement is a very controversial
point.
Bronchoscopy-Bronchoscopy is used to
get a biopsy sample in cases where the
lungs are primarily involved. Only rarely
does tracheal or bronchial blockage occur
with sarcoidosis, but one case has been
reported in which the lesions were found
involving the trachea itself and the
resulting obstruction was removed by
bronchoscopy.
Biopsy-Biopsy is the one method of
making a positive diagnosis. Any superficial gland may be biopsied. If only
intrathoracic glands are seen, a positive
scalene node biopsy has been reported in
many cases. Any tissue can be biopsied
and some clinics advocate biopsy of any
of the salivary glands, bone marrow or
liver if lymphadenopathy is absent. Liver
biopsy is positive in a high percentage
of cases but many use the technique spar-
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Kveim-Nickerson Skin Test-The KveimNickerson test involves the intradermal
injection of a heat-sterile suspension of
human sarcoid tissue and the development
of a skin reaction within a few weeks
time around the point of injection. Using
the presence of the skin reaction as well
as a biop-sy and histological examination
of the site of injection carried out 4-6
weeks post injection, Siltzbach and Erlich
found the following results in a series of
192 patients:
58 positive sarcoids--86% positive.
80 sarcoid suspects--33 strong, 85%
positive; 47 weak, 27 % positive.
54 with other diseases - 4% false
positive.

Using a control suspension of normal
lymp node and splenic tissues, no reactions were noted. Since it shows a high
degree of accuracy, this test is very useful as a confirmatory diagnostic tool,
especially if there is not tissue available
for biopsy. The test is somewhat limited
in its use because of the severity of the
resulting skin reaction and the prolonged
time (months to a year) that it takes for
the reaction to disappear.
In summary the main diagnostic criteria are:
1. Clinical and radiological evidence
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in biopsy material
3. Negative bacteriological studies or
biopsy or necrosy material
5. Laboratory evidence including the
positive skin test
TREATMENT
A method of prophylaxis cannot be
recommended until the etiology of the
disease is known. Throughout the years,
numerous methods of treatment have been
tried for patients with sarcoidosis. Ultra
violet light, X-rays and radium have been
used extensively and although they may
possibly benefit some superficial lesions,
no satisfactory results are demonstrable in
other tissues. Arsenic, tuberculin, calciferol, various antibiotics, nitrogen mustard and urethane have also been used.
The occasional case has shown improvement on these therapies, but none can be
used with any degree of assurance of obtaining cure beyond that of random
chance.
The antituberculous drugs streptomycin,
dihydrostreptomycin and isoniazid have
been given thorough trials, but with little
success. The literature now being published stresses only the ineffectiveness of
these drugs in sarcoidosis. This seems to
be further proof that tuberculosis and
sarcoidosis are different diseases.
The only encouraging reports of successful treatment are those following the
use of dihydrotachysterol, ACTH and
Cortisone. Although effective on numerous occasions, the use of dihydrotachysterol is limited by the drug's toxic effects.
Many glowing reports appear about
the marked clinical and radiological improvement obtained from ACTH and
Cortisone therapy, but Woolner and
Hodgson at the Mayo Clinic feel that
these are the exceptional rather than the
common findings. Mostly the improvement is limited to the clinical response,
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with no appreciable radiological change.
In ACTH and Cortisone therapy, one
must always be aware of the dangers associated with their use in the presence of
tuberculosis. The regime used by these
men at the Mayo Clinic consists of 100
mgm of Cortisone daily until a remission occurs or until one to two weeks of
treatment have elapsed. The dosage is
then slowly diminished to a maintenance
level of 50 mgm per day.
If ACTH is used, the initial dose should
be 60-100 mgm per day with a gradual
reduction after 1-2 weeks of therapy to
a maintenance level of 10 to 25 mgm
per day. Therapy may have to be maintained for weeks or months if progressive
clinical improvement is noted.
Ocular lesions regress well with ACTH,
and lung lesions respond to either ACTH
or Cortisone. However, Siltzbach noted
a relapse rate of 70% once therapy was
stopped, and he felt these drugs had little
effect on the natural course of the disease.
Many patients with lung involvement
seem to have worse pulmonary function
following therapy. Stone et al suggest
these people were in the granulomatous
stage of the disease and that the lesions
healed rapidly with marked hyalinization
and resulting severe pulmonary fibrosis.
Surgery is used most infrequently in
sarcoidosis, with its main contributions
being in the field of biopsy to get tissue
for diagnosis and very rare splenectomy
when splenic symptoms are severe.
In evaluating the success of any therapy one must be cognizant of the natural
course of the disease and realize that most
patients tend to improve without therapy.
Hence the aim of the therapist in using
ACTH, Cortisone or any drug should be
to carry the patient temporarily until
spontaneous remission occurs or is induced by the therapy as happens in a
small percentage of cases.

U.W.O. MEDICAi: jouRW.i.

PROGNOSIS
The prognosis of sarcoidosis is extremely variable, since the disease onset
is very insidious and the disease itself
may remain completely asymptomatic.
Once diagnosed and treated it may remain
latent for years and then suddenly flare
up and proceed to fatal termination.
In Leitner's 1949 series death resulted
primarily from secondary complications.
The causes of death were classified as
follows:
46% from cardiac failure
20% from superimposed tuberculosis
16% from CNS sarcoidosis
18% from secondary bacterial infections and miscellaneous causes.
Several cases of heart failure· due to
myocardial sarcoidosis have been reported,
but usually failure occurs secondary to a
cor pulmonale resulting from a severe lung
fibrosis.
King and Reisner, in a series of 64
cases, showed that at the end of 3 years:
36 cases
or
16 cases
12 cases

or 56.2% had cleared totally
partially;
or 25 % remained static;
or 18.8 % had progressed.

CLINICAL CHEMISTRY
IN PRACTICAL MEDICINE
C. P. Stewart, Reder in Classical Chemistry; D. M. Dunlop Christison, Professor
of Therapeutics and Clinical Medicine,
University of Edinburgh. 320 pages,
illustrated. E. and S. Livingstone LJd.,
Edinbttrgh and London, 1954.
This book is a refreshing, clear, concise and comprehensive review of the field
of practical clinical chemistry. One is
impressed with the clarity of expression
ana the ease with which the authors present their material.
The book contains the following topics:
the collection and preservation of sam-
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On an overall study, Carr and Gage at
the Mayo Clinic give a 5 year survival
rate of 92.9% and a 10 year survival of
80 % . Cowdell in England gives a rate
only 2-5 % below that quoted above. Thus
we see that the prognosis for life is good,
but that the prognosis for the healing of
the lesion and disappearance of symptoms is only fair.
In conclusion, little has been done to
advance our knowledge of sarcoidosis until recently. However, with the development of better diagnostic methods, the
incidence of the disease is greater than
previously was suspected. Many etiological theories have been advanced and
remain as theories, with little or nothing
positive being known of the actual cause.
This hck of knowledge limits the therapeutics applicable to the treatment of the
disease to non-specific and empirical entities. It is to be hoped, therefore, that in
the near future, the etiology of the disease will be more clearly defined and specific therapies found . Until then, one can
only endeavour to make the clinician more
aware of the existence of the condition
so that it may be diagnosed and treated
with the drugs now showing the most
success.

ples; water and electrolyte metabolism;
neutrality regulation ; carbohydrate metabolism ; tests of renal function; the proteins of blood plasma; tests of gastric,
pancreatic and hepatic function ; the cerebro-spinal fluid ; assessment of thyroid
function; calcium and phosphorus; hormone abnormalities; nutritional deficiences. The theory behind the clinical
chemical tests is presented in a simple
but didactic manner. Included are a number of excellent graphs and tables which
summarize the written portion of the text
as well as presenting other useful data.
Various tests and their limitations are included in an appendix, making them
available for quick reference.
-Victor Priebe, '57
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Book Reviews
PEARCE GOULD'S ELEMENfS
OF SURGICAL DIAGNOSIS
10th Edit. Sir Cecil Wakely, P4111 B. Hoeber
Inc., The Ryerson Preu.
This text is one which should prove to
be of great value to the student who is
commencing the study of clinical medicine and surgery. The book has been
written primarily for this purpose. In general it is intended for reference work, but
also contains excellent material for reviewing purposes.
The author presents and discusses surgery from the viewpoint of clinical symptomatology. This type of organization is
excellent for the student who has to review a great deal of material in a limited
time. The text contains seventy-nine
plates, 556 pages and an excellent index.
Gould's Elements of Surgical Diagnosis
should prove to be a popular book.
-Marvin L. Kwitko, '56

THE FOUNDATIONS
OF SURGERY
George Perkins, F.R.C.S. E. and S. Liflingstone, Edinburgh and London; The Macmillan Co. of Canada, Lid.
This simple surgical text is exactly what
the author states - elementary, basic,
pocket-sized and concise. Each topic is
arranged under the headings of symptoms, treatment and rehabilitation. Topics
included in the book are: healing of
wounds; burns; infection; examination of
body parts; coma and collapse; disc
surgery.
This is a small text which will help
prepare the neophyte for the more formidable text-books of surgery.
-Travis Kaylor, '57

GLANDULAR PHYSIOLOGY
AND THERAPY
Multiple t~~~thors. J. B. Lippincott Company,
Montreal. (Prepared under the t~~~spices
of the Council on Pharmacy and Cbemistry of the American Medical Associatiotl), Ed. 5, 1954.
This work leaves one with the impression that nothing has been omitted
except that experimental detail which is

often superfluous to the average reader
and which, in fact, mars some of our
otherwise excellent reference text-books
on physiology. This text, on the other
hand, includes sufficient experimental
data to make the book both tnteresting
and authentic.
The emphasis in each chapter has been
placed upon treatment, but the traditional approach, with discussion of anatomy, physiology and abnormalities of
function , has been followed in order to
give a better understanding of the basic
principles underlying treatment.
Twenty to thirty years ago the physiology of the endocrine glands was fairly
well understood. However, the clinician
was still besieged by an infinite number
and variety of hormones, pseudohormones,
and general hormonal elixirs of life and
fountains of youth which were claimed
to cure everything from athlete's foot to
dandruff. In other words, what to do?
Until the publication of this book, there
were very few good references on actual
application of the new substances which
were gradually being isolated and purified for use. Hence, the original ed1tion
of Glandular Physiology and Therapy was
born in 1924.
The value of this particular work on
endocrinology is two-fold . Firstly, it is
not a semi-rehashed version of an old
textbook but is virtually a new work in
each edition, since tbe material is gathered from current journals (most of which
are post-war). Secondly, each subject is
dealt with by individual specialists in that
particular field . Tbe whole work is scientifically co-ordinated with an introdutory
chapter by Hans Selye, Professor and
Director of Experimental Medicine at the
University of Montreal, and Paul Rosch,
of Albany, New York; it is literarily coordinated by the Committee on Publications, Council on Pharmacy and Chemistry of the A.M.A.
The above-mentioned committee bas
done an excellent job in editing a
work which is easily read and understood by tbe student, but which also
provides the specialist with much condensed information.
-Jay Webster, ''7
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Intern Placements
NAME

HOSPITAL

ADAMS, Kenneth W ..... ....... .. ....... ......... ........... ............... .General, Hamilton, Ont.
BEBENSEE, Donald .......... ........... ... .... .... ..... ............ ... Wayne County, Eloise, Mich.
BOTA, William ............ ...... ... .... .. .... .... ...... .......................... General, Hamilton, Ont.
BROWN, James ..... ......... ... ........ ......... .. .......... ...... ...... ........ Western, Toronto, Ont.
CARRUTHERS, John ............ ... .. ..... ... .. ...... .. .. .... ........ ........ General, Toronto, Ont.
CATTON, Donald ... ........ ... ....................................... ... ....... Victoria, London, Ont.
CERNAVSKIS, Velta ......... .... ... .. .... ............ .................... St. Joseph's, Toronto, Ont.
CHAGNON, Edward ....... .. ...... ... ..... .......... ....... ................. General, Hamilton, Ont.
CHARTERIS, Richard .. ... ....... ... ..... .. .. ... ................. .......... St. Vincent's, Toledo, Ohio
COLLYER, Robert... ...... ..... ......... .. ... ........... ...... ........... ... .... Victoria, London, Ont.
CRISPIN, Edward .............................. ..... ............. ... ..... ....... General, Montreal, P.Q.
DEINUM, Jeanne ... .. .......... ...... ...... ....... .. ............ ... ... ..... ......... Victoria, London, Ont.
EDDY, Robert.. .............. ..... ......... . ................... .. ............. East General, Toronto, Ont.
EISTETTER, Alfred ..... .... ......... ................... .. ... ................... .... City, Saskatoon, Sask.
EDWARDS, John .... ... ... .. ............. .... .. ................................. Western, Toronto, Ont.
FORBES, David .... .............. ...... ................ ..... ...... ................ General, Montreal, P.Q.
GOLDMAN, Leonard ..................................... Temple University, Philadelphia, Pa.
GRANT, Douglas ............................. ............ ........ ..... .......... .... Victoria, London, Ont.
GROSH.AW, Ronald ......... ..... ........... ........................... .......... Victoria, London, Ont.
HAMILTON, Gavin ...... ... ................. .. .............................. ... ... Victoria. London, Ont.
HENDERSON, Murray .......... .. ... .. ..... ....... ............................ .Victoria, London, Ont.
HOBBS, Kenneth ...... .. ..... ...... ............ .. ......................... ... ... .......... Civic, Ottawa, Ont.
HUTSON, Richard ......... ..... .. ... ............. ... .... ............ .... ...... .......... .Civic, Ottawa, Ont.
IRVINE, John ....... .... .... ....... ... ... .. .. ..... .................................... .Victoria, London, Ont.
IWAN, Stanley ....................... .. ........ ... ... .. ... .......... .. .. ........... ... Western, Toronto, Ont.
JACKSON, Harold ................. ..... ........... ..... ................. ......... General, Hamilton, Ont.
JOHNSON, Harold ....... .......... .. ...... ..................................... General, Hamilton, Ont.
JORY, Thomas ... ... ...... .. .. .......... ............. ..................... ..... ... ...... Victoria, Loncf.,..n, Ont.
KINGSMILL, Sheila .. ........................ .. ................. .. ............... Victoria, London, Ont.
KIRSH, Erving ................ ..... ... ......... .. .. .. ..................... .. ...... ... .General, Toronto, Ont.
KNIGHT, Charles .... ....... ....... .. .. ... ..... .... ... ........ ... ..... ... .. ...... .. .. Victoria, London, Ont.

MAY, 1955

,95

NAME

HOSPITAL

MALONEY, Alan .......................... ................. .......... .......St. Michael's, Toronto, Ont.
MATHIES, Helmut. .. .... .... ........ .... .. ......... .. ....... ... .... ... ...... .... ... Victoria, London, Oat.
MORRISON, Joseph ..... .... .... ...... .......... . ...... .. ..... ... ..... .St. Joseph's, Hamilton, Ont.
MOSSING, Shirley........ .... ...... .... ....... ... .................. .... ....... .. ... General, Regina, Sask.
MUNRO, Donald ..... .... .................. ....... ...... .......... ........ .. .. .... General, Hamilton, Ont.
MacDONALD, Craig ..... ..... ..... ..... ........ .... ... .... .. ...... ................. Victoria, London, Oat.
McKNIGHT, Kenneth ....... ........... .. ...... ... ........... .......... ... .. .... .Victoria, London, Ont.
McLEAN, William ....... ...... ......................... .... .. ........... ....... General, Hamilton, Ont.
NATHAN, Max ........ ................... .... ....... ... ... ... ......... .. ....... .... ... Victoria, London, Oat.
PEARCE, George .. ........... ....... .... ......... .......... ... ......... .. ........... General, Toronto, Ont.
POLAK, Alexander .. .... .......... .. ....... ... .. .......... .. .............. .......... General, Toronto, Oat.
PORTER, Robert. ............. .. .......... .......................... ..... ......... General, Hamilton, Ont.
RHODES, John ... ...................... .................. .. ........ .. .. ...... ......... Victoria, London, Ont.
ROBERTS, Richard ........... .... .. ......... .. ........ .......... .. ..... ........... General, Montreal, P.Q.
SALES, Jack................. ..... ........ .... .. .. .. .. ... .. ............................. Victoria, London, Ont.
SHAVER, Jack......... .......... .. ... .. ....... ............. ... ................. .... .. General, Hamilton, Ont.
STANTON, James ................................................................ St. Francis, Evanston, Ill.
STRATFORD, Graham .. ...... .... .......... .. .. .................. .Royal Victoria, Montreal, P.Q.
SWAN, Donald ................. ... ....... .............. ......... .. ......... ... ..... ....... Sinai, Detroit, Mich.
THRENDYLE, Kenneth .. .................. ... ............................. ... Victoria, London, Ont.
TURNBULL, Kenneth ...... ....... ... ..... .. .. .. ... .... .... .... .. .... ... .... .... ... General, Regina, Sask.
TURNER, Robert. ............. ... .. ......... .... ........ ... ....... .................................. London, Ont.
UPMALIS, Henry ...... ...... ........ ........ ....... .. ...... .. ................ .. ..... Victoria, London, Ont.
URSCHEL, John ...................... .... ........ ...... University of Alberta, Edmonton, Alta.
V ASARINSH, Pavils...... .. .. ........................ .... ...... .. .... .... ...... General, Hamilton, Oat.
WALLACE, John ...... .... ............. ........... ...... .. .......................... General, Calgary, Alta.
WEBER, James ...... .......... ............ ... .. ....... ..... ........... .... .. ..... ..... Western, Toronto, Ont.
Y ANKOU, Cluis .... .... .................................. ................... East General, Toronto, Oat.
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